SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,593.24 -1,045.46
( -1.44%)

Global Indices

Nasdaq

51,194.40 -347.88
(-0.67%)

Dow Jones

7,822.15 -17.78
(-0.23%)

Hang Seng

69,343.08 -692.63
(-0.99%)

Nikkei 225

10,456.95 -84.74
(-0.80%)

Forex

USD-INR

96.37 0.10
(0.10%)

EUR-INR

108.33 0.45
(0.42%)

GBP-INR

127.68 0.44
(0.34%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Symbiotec Pharmalab Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544889

INE899I01028

195.2322192

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYMBIOTEC

46.62

7267.04

EPS(TTM)

Face Value()

Div & Yield %

24.26

Back

saregama india ltd

Pritika Engineering Components consolidated net profit rises 46.80% in the June 2026 quarter

Aug 07,2026

Net profit of Pritika Engineering Components rose 46.80% to Rs 2.98 crore in the quarter ended June 2026 as against Rs 2.03 crore during the previous quarter ended June 2025. Sales rose 42.40% to Rs 52.93 crore in the quarter ended June 2026 as against Rs 37.17 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	52.93	37.17	42
OPM %	12.13	14.66	-
PBDT	4.69	4.08	15
PBT	2.54	2.43	5
NP	2.98	2.03	47

71,593.24 -1,045.46 ( -1.44%)

51,194.40 -347.88 (-0.67%)

7,822.15 -17.78 (-0.23%)

69,343.08 -692.63 (-0.99%)

10,456.95 -84.74 (-0.80%)

96.37 0.10 (0.10%)

108.33 0.45 (0.42%)

127.68 0.44 (0.34%)

0.61 0.00 (0.01%)